Sana Biotechnology, Inc.

NASDAQ:SANA

4.29 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -283.255-269.476-355.928-285.305-130.778-13.247
Depreciation & Amortization 30.86515.62511.075.9211.8260.001
Deferred Income Tax -96.236000-7.5470
Stock Based Compensation 35.53338.33722.3625.8281.4970.118
Change In Working Capital 18.6117.5429.8016.15610.526-0.308
Accounts Receivables 000000
Inventory 000000
Accounts Payables 1.0271.058-0.2661.982-0.4210.289
Other Working Capital 17.5846.48410.0674.17410.947-0.597
Other Non Cash Items 40.9-82.07861.641129.41838.972-0.228
Operating Cash Flow -253.582-290.05-251.054-137.982-85.504-13.495
Investing Activities:
Investments In Property Plant And Equipment -20.032-20.876-29.862-23.872-26.183-0.46
Acquisitions Net -0.192-0.23100.229-3.1950
Purchases Of Investments -157.744-78.688-491.387-387.432-141.5190
Sales Maturities Of Investments 349.788310.126280.025158.74182.9770
Other Investing Activites 0.1920.231-4.574-0.2290.059-0.32
Investing Cash Flow 172.012210.562-245.798-252.563-87.861-0.78
Financing Activities:
Debt Repayment 000000
Common Stock Issued 31.6464.913631.7510.1490.00145.721
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 0.0324.913631.751435.538223.72591.442
Financing Cash Flow 31.6464.913631.751435.687223.72645.721
Other Information:
Effect Of Forex Changes On Cash 4.40800000
Net Change In Cash -45.516-74.575134.89945.14250.36131.446
Cash At End Of Period 137.349187.273261.848126.94981.80730.63